Showing 2041-2050 of 2898 results for "".
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- BTL Introduces EMFACEhttps://modernaesthetics.com/news/btl-introduces-emface/2473301/BTL is taking on the minimally invasive facial aesthetic category with the launch of EMFACE. Emface simultaneously emits both
- BeautyHealth’s Hydrafacial Partners with Organicell for Exosome Boosterhttps://modernaesthetics.com/news/beautyhealths-hydrafacial-partners-with-organicell-for-exosome-booster/2473300/The Beauty Health Company is joining forces with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin for Hydrafacial. “We are excited to begin development with Organicell to co-create a potentially
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum
- Physician Growth Partners Advises on Women's Health Partnership in Chicagohttps://modernaesthetics.com/news/physician-growth-partners-advises-on-womens-health-partnership-in-chicago/2473293/Through a new partnership, Together Women’s Health, a portfolio company of Shore Capital Partners, has entered into the Chicago market and will empower The Northwestern Specialists for Women with significant resources to continue its growth.
- Revision Skincare, RVL Pharmaceuticals Form Partnershiphttps://modernaesthetics.com/news/revision-skincare-rvl-pharmaceuticals-form-partnership/2473288/Revision Skincare® is partnering with RVL Pharmaceuticals, Inc. the owner of UPNEEQ®, to collaborate on a variety of marketing efforts within the medical aesthetics industry, working together to address significant unmet consumer needs. Revisions says that, with shared
- Lullage Launches Skincare for White Patcheshttps://modernaesthetics.com/news/lullage-launches-skincare-for-white-patches/2473282/Lullage has launched Repigment12 White Patches Corrector Face & Body Cream containing proprietary Repigma12 peptide, a blend of 12 amino acids that provides an innovative mechanism to help restore skin's natural tone. The formula, which took more than five years of development, was c
- The Newest Xeomin Brand Partner is Joe Jonashttps://modernaesthetics.com/news/the-newest-xeomin-brand-partner-is-joe-jonas/2473280/Joe Jonas is the latest Xeomin (incobotulinumtoxinA) brand partner, Merz Aesthetics announced. The U.S. partnership with Jonas kicks off a new ‘Beauty on Your Terms’ campaign for Xeomin and represents the first time the singer, songwriter and actor has pa
- Aesthetics Biomedical Inc. Scores Third U.S. Patent for SoME Skincarehttps://modernaesthetics.com/news/aesthetics-biomedical-inc-scores-third-us-patent-for-some-skincare/2473277/Aesthetics Biomedical Inc. scored its third U.S. patent for “biological preserving composition and methods of use” for its SoME skincare product line. The patent covers topical compositions for combining biologics with skincare preserving the exclusivity of SoME Skincar
- JUVÉDERM VOLUX XC Scores FDA Nod for Jawline Definitionhttps://modernaesthetics.com/news/juvederm-volux-xc-scores-fda-nod-for-jawline-definition/2473275/The U.S. FDA has given its nod to JUVÉDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition. "The approval of JUVÉDERM VOLUX XC represents the largest leap in innova